Table 6.

Estimated bioavalibity of trans-resveratrol (RES), trans-resveratrol-3-sulfate (R3S) and resveratrol-3-O-β-D-glucuronide (R3G) in male and female HSD rats and B6C3F1/N mice following gavage administration of RES

	RES (%)		R3S (%)		R3G (%)
	Male	Female	Male	Female	Male	Female
Rats
312.5 mg/kg	15.1	21.0	38.2	57.5	68.7	65.0
625 mg/kg	11.5	15.1	36.1	67.6	38.6	35.0
1250 mg/kg	23.7	30.6	68.5	63.1	102.0	43.8
Mice
625 mg/kg	3.3	4.2	42.2	13.0	63.6	66.0
1250 mg/kg	2.6	5.9	15.8	9.4	37.3	55.8
2500 mg/kg	3.0	2.5	10.4	4.5	30.5	57.8